Recruiting Prostate Cancer Studies in Syracuse
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients wi...
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
The purpose of this study is to evaluate the efficacy and safety of AAA617 alone (Lutetium \[177Lu\] vipivotide tetraxetan) and in combination with an Androgen Receptor Pathway Inhibitors (ARPI) in pa...
About Prostate Cancer Clinical Trials in Syracuse
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Syracuse, NY. These studies are seeking a combined 255 participants. Research is being sponsored by AstraZeneca, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Syracuse — FAQ
Are there prostate cancer clinical trials in Syracuse?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Syracuse, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Syracuse?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Syracuse research site will contact you about next steps.
Are clinical trials in Syracuse free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Syracuse studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Syracuse are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov